Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG

Pentoxifylline 400 MG

Pentoxifylline (PTX) is a methyl-xanthine derivative that possesses antioxidant and anti-inflammatory characteristics

Trial Locations (1)

RECRUITING

Faculty of Medicine, Mansoura University, Al Mansurah

All Listed Sponsors

lead

Tanta University

OTHER